Posts tagged natural lens
EyeGate developing non-invasive ophthalmic treatments

EyeGate Pharmaceuticals (NASDAQ:EYEG) is developing a non-invasive drug delivery platform that uses an electrical process, known as iontophoresis, to deliver a corticosteroid to the front-and back-of-the-eye for the treatment of ophthalmic conditions, such as anterior uveitis, macular edema and post-cataract surgery inflammation.

“Our EyeGate II Delivery System addresses two of the most prevalent issues in ophthalmic care: the existing lack of patient compliance with eye drops and patient safety from the use of intravitreal injections,” president and CEO, Stephen From, says in an interview with

EyeGate, which went public 11 months ago, signed an exclusive, worldwide licensing agreement last summer with the Bausch & Lomb subsidiary of Valeant Pharmaceuticals International (NYSE, TSX:VRX) for its EGP-437 corticosteroid in the field of uveitis, as well as a right of last negotiation to license the product for other indications.

Read More